Personalised and on-the-spot therapy: deep brain stimulation

Advances

“Patients have a very good efficacy of the stimulation, so they reach the best level they can with medication in a very stable therapy, no fluctuations at all”

Professor François Alesch, neurosurgical investigator, Medical University Vienna

Overall, the study shows that the motor skills of patients with a Vercise^TM DBS system improved significantly.¹ This improvement in motor function came along with an improvement in the daily activities of living.² Furthermore, people with Parkinson’s could also reduce their medication intake compared to the time prior to the procedure.³

References:

¹ Unified Parkinson’s Disease Rating Scale Part III (UPDRS III).

² Quality of life assessed with Parkinson’s Disease Questionnaire (PDQ-39) Schwab and England and motor diaries.

³ Calculated using levodopa equivalents.

This article is sponsored by Boston Scientific. The information in this article is given for information purposes only and does not represent an endorsement by Parkinson’s Europe of any particular treatments, products or companies. This article is not a substitute for advice from your doctor, pharmacist or other healthcare professional. Parkinson’s Life makes no representations or warranties of any kind, express or implied, about the completeness or accuracy of information provided

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Air time: the radio station that’s giving people with Parkinson’s a voice

ON AIR – meet your hosts, Radio Parkies

Ask the expert: Can environmental factors cause Parkinson’s?

Dr Ray Dorsey on the impact of pesticides

“Life isn’t easy”: how coronavirus is affecting women with Parkinson’s

Four women with Parkinson’s share their experience of lockdown

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…

Study explores predictors of cognitive impairment in Parkinson’s disease

Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.

Could frailty be a potential risk factor for Parkinson’s disease?

Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Personalised and on-the-spot therapy: deep brain stimulation

Advances

sponsored by Boston Scientific

Author: SponsoredPublished: 4 February 2016

Prep: Cook: Serves:

“Patients have a very good efficacy of the stimulation, so they reach the best level they can with medication in a very stable therapy, no fluctuations at all”

Last Month

Next Month

Share this story

Comments

Perspectives

Air time: the radio station that’s giving people with Parkinson’s a voice

Special reports

Ask the expert: Can environmental factors cause Parkinson’s?

Women and Parkinson's

“Life isn’t easy”: how coronavirus is affecting women with Parkinson’s

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

Could frailty be a potential risk factor for Parkinson’s disease?

{title}

Subscribe

Personalised and on-the-spot therapy: deep brain stimulation

Advances

sponsored by Boston Scientific

Author: SponsoredPublished: 4 February 2016

“Patients have a very good efficacy of the stimulation, so they reach the best level they can with medication in a very stable therapy, no fluctuations at all”

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Air time: the radio station that’s giving people with Parkinson’s a voice

Special reports

Ask the expert: Can environmental factors cause Parkinson’s?

Women and Parkinson's

“Life isn’t easy”: how coronavirus is affecting women with Parkinson’s

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

Could frailty be a potential risk factor for Parkinson’s disease?

{title}

Subscribe

Sign in